BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

BioRestorative Therapies, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026

$1.60+0.06 (+3.90%)

Close on Oct 19, 2026

Community

Notes and questions about BioRestorative Therapies from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in BioRestorative Therapies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Sep 8, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BRTX.

Revenue growth-8.5% · median -24.0%

Gross margin92.1% · median 44.6%

Operating margin-3975.0% · median -2454.5%

Net margin-3089.6% · median -2344.6%

Advertisement
300 × 250